GrubHub Inc. made a big splash in its trading debut Friday, but next week may test the size of investor appetites for initial public offerings. It’s a busy week with 15 companies expected to emerge. Here’s a glance at the companies scheduled to go public:
Adamas Pharmaceuticals Inc. – The Emeryville, Calif.-based brain drug developer creates products for central nervous system disorders such as Parkinson’s and Alzheimer’s. It is one of several drug makers to go public this year. The company has a deal with Forest Laboratories for co-creation of a dementia drug, which is pending FDA approval.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.